Literature DB >> 22012463

Bat severe acute respiratory syndrome-like coronavirus ORF3b homologues display different interferon antagonist activities.

Peng Zhou1, Hongxia Li1, Hanzhong Wang1, Lin-Fa Wang2, Zhengli Shi1.   

Abstract

The ORF3b protein of severe acute respiratory syndrome coronavirus (SARS-CoV) has a nuclear localization signal (NLS) at its C terminus and antagonizes interferon (IFN) function by modulating the activity of IFN regulatory factor 3 (IRF3). SARS-like coronaviruses (SL-CoVs) found in bats share an identical genome organization and high sequence identity for most of their gene products. In this study, ORF3b homologues were identified from three bat SL-CoV strains. These ORF3b homologues were C-terminally truncated and lacked the C-terminal NLS of SARS-CoV. IFN antagonist activities analysis demonstrated that one SL-CoV ORF3b still possessed IFN antagonist and IRF3-modulating activities. These results indicate that different ORF3b proteins display different IFN antagonist activities and this function is independent of the protein's nuclear localization, suggesting a potential link between bat SL-CoV ORF3b function and viral pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22012463     DOI: 10.1099/vir.0.033589-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.

Authors:  Adriaan H de Wilde; Kazimier F Wannee; Florine E M Scholte; Jelle J Goeman; Peter Ten Dijke; Eric J Snijder; Marjolein Kikkert; Martijn J van Hemert
Journal:  J Virol       Date:  2015-06-03       Impact factor: 5.103

2.  Bat Severe Acute Respiratory Syndrome-Like Coronavirus WIV1 Encodes an Extra Accessory Protein, ORFX, Involved in Modulation of the Host Immune Response.

Authors:  Lei-Ping Zeng; Yu-Tao Gao; Xing-Yi Ge; Qian Zhang; Cheng Peng; Xing-Lou Yang; Bing Tan; Jing Chen; Aleksei A Chmura; Peter Daszak; Zheng-Li Shi
Journal:  J Virol       Date:  2016-06-24       Impact factor: 5.103

3.  MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment.

Authors:  Adriaan H de Wilde; V Stalin Raj; Diede Oudshoorn; Theo M Bestebroer; Stefan van Nieuwkoop; Ronald W A L Limpens; Clara C Posthuma; Yvonne van der Meer; Montserrat Bárcena; Bart L Haagmans; Eric J Snijder; Bernadette G van den Hoogen
Journal:  J Gen Virol       Date:  2013-04-25       Impact factor: 3.891

Review 4.  The molecular virology of coronaviruses.

Authors:  Ella Hartenian; Divya Nandakumar; Azra Lari; Michael Ly; Jessica M Tucker; Britt A Glaunsinger
Journal:  J Biol Chem       Date:  2020-07-13       Impact factor: 5.157

Review 5.  Origin and evolution of pathogenic coronaviruses.

Authors:  Jie Cui; Fang Li; Zheng-Li Shi
Journal:  Nat Rev Microbiol       Date:  2019-03       Impact factor: 60.633

Review 6.  Host Factors in Coronavirus Replication.

Authors:  Adriaan H de Wilde; Eric J Snijder; Marjolein Kikkert; Martijn J van Hemert
Journal:  Curr Top Microbiol Immunol       Date:  2018       Impact factor: 4.291

7.  Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan.

Authors:  Jasper Fuk-Woo Chan; Kin-Hang Kok; Zheng Zhu; Hin Chu; Kelvin Kai-Wang To; Shuofeng Yuan; Kwok-Yung Yuen
Journal:  Emerg Microbes Infect       Date:  2020-01-28       Impact factor: 7.163

8.  Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus.

Authors:  Ben Hu; Lei-Ping Zeng; Xing-Lou Yang; Xing-Yi Ge; Wei Zhang; Bei Li; Jia-Zheng Xie; Xu-Rui Shen; Yun-Zhi Zhang; Ning Wang; Dong-Sheng Luo; Xiao-Shuang Zheng; Mei-Niang Wang; Peter Daszak; Lin-Fa Wang; Jie Cui; Zheng-Li Shi
Journal:  PLoS Pathog       Date:  2017-11-30       Impact factor: 6.823

9.  Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic.

Authors:  Chase W Nelson; Zachary Ardern; Tony L Goldberg; Chen Meng; Chen-Hao Kuo; Christina Ludwig; Sergios-Orestis Kolokotronis; Xinzhu Wei
Journal:  Elife       Date:  2020-10-01       Impact factor: 8.140

Review 10.  C1 esterase inhibitor and the contact system in COVID-19.

Authors:  Timothy M Thomson; Emily Toscano-Guerra; Ernesto Casis; Rosanna Paciucci
Journal:  Br J Haematol       Date:  2020-07-28       Impact factor: 8.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.